LMG Life Sciences Awards EMEA 2022: information and updates

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

LMG Life Sciences Awards EMEA 2022: information and updates

lmg-life-sciences-awards-for-dat-600x400-emea.png

Important information and updates for the LMG Life Sciences Awards 2022

We are excited to inform you that the preeminent industry recognition programme for legal work in the life sciences industry, LMG Life Sciences Awards, is returning for 2022.


As you may have seen, we have updated the title of the awards to be inclusive of firms not only in Europe but also throughout the Middle East and Africa. 



In our research cycle we will ask that you submit nominations for leading practitioners, firms, cases, and deals. 



We will be recognising the top work completed by private practice firms, as well as in-house counsel, from 2021. 



Register your interest today so you do not miss out! 


more from across site and ros bottom lb

More from across our site

Niall Trainor, managing attorney at Hasbro, says brands could boost their business with careful portfolio culling
A decision by the Paris Central Division will lead to more IP work for outside counsel, say sources
Courts are encouraged to deliver judgments within three months of a trial, but that deadline has been missed in several recent cases
Lawyers at Maiwald and Sterne Kessler analyse how patents with claims directed to medical treatments are handled in the US and in Europe
Michael DeVincenzo explains how he and his team convinced the Federal Circuit to find in favour of his client in a patent case against Salesforce
Funders and a litigator explain how litigation funding disclosure requirements could affect their business
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
Discussions about whether to seek director reviews can come up frequently with clients, even though actual grant rates are rare
In the latest episode, we discuss why IP firms might be attractive to PE investors and bring you the latest news on submissions for next year’s IP STARS rankings
Back-to-back PE deals for IP firms in recent years show that IP firms are sitting on goldmines, so traditional partnerships should be open to change
Gift this article